www.fdanews.com/articles/102591-taxus-drug-eluting-stent-system-receives-ce-marking-for-use-in-diabetic-patients

Taxus Drug-Eluting Stent System Receives CE Marking for Use in Diabetic Patients

December 26, 2007

Boston Scientific Corporation announced that its Taxus Liberte paclitaxel-eluting coronary stent system has received European CE Mark approval for use in patients with diabetes.
Boston Scientific